Articles by Daniel Marsh
Netflix Shares Dip After-Hours as Warner's UK Streaming Move Revives Deal Focus
Netflix stock declined 0.9% in extended trading following Warner Bros Discovery's announcement of HBO Max's UK launch and corporate restructuring plans that could shift entertainment assets to Netflix.
Dow Holds 50,000 as Markets Await Key Jobs, Inflation Data
The Dow Jones Industrial Average edged up 17 points to 50,132.79, maintaining its position above the 50,000 threshold. Investors are focused on upcoming employment and inflation reports, which could influence Federal Reserve policy.
Intel Retreats in Extended Trading as Investors Eye Economic Data, Chip Sector Diverges
Intel shares declined 0.7% in after-hours trading following a volatile session, while rivals Nvidia and AMD advanced. Market focus shifts to upcoming U.S. jobs and inflation reports.
Microsoft Rebounds 3% as Software Stocks Recover from AI Selloff
Microsoft shares gained 3.1% to $413.68, lifting its market cap to $3.59 trillion. The rebound follows a sector-wide pullback, with analysts divided on AI spending and cloud capacity constraints.
Apple Shares Dip in Extended Trading Ahead of Key Economic Data
Apple shares declined 1.3% in after-hours trading Monday, underperforming a broader tech rally as investors await U.S. jobs and inflation reports. The company's annual shareholder meeting is scheduled for February 24.
BlackRock Shares Gain on Deutsche Bank Aladdin Integration and Fund Restructuring
BlackRock's stock rose 2.5% following an FX workflow automation partnership with Deutsche Bank and a consolidation of municipal closed-end funds. Investors await CFO commentary and key economic data.
Seagate Shares Dip Amid Analyst Target Hikes, Macro Data in Focus
Seagate stock declined 0.4% to $427.48 despite Loop Capital raising its price target to $700. Investors await U.S. jobs and inflation data for interest rate signals.
Amgen Shares Slide on FDA Setback and Enbrel Weakness, Pressuring Dow
Amgen stock fell nearly 2% Monday, pressured by an FDA request to withdraw rare-disease drug Tavneos and a sharp 48% quarterly drop in Enbrel sales. The decline weighed on the price-weighted Dow Jones Industrial Average.
Cummins Shares Surge on Upgraded Price Target, Data Center Demand in Focus
Cummins stock climbed over 4% after Raymond James raised its price target to $675, citing data center power needs and a potential truck market recovery. Investors await the May 21 Analyst Day for strategic updates.
Philip Morris Shares Dip Amid Zyn Competition and Debt Filing
Philip Morris International stock declined 1.4% to $180.17 as investors weighed nicotine pouch rivalry and a new debt shelf registration. Several analysts raised price targets following the company's 2026 outlook.
Arrowhead Sees Volatility After S&P MidCap 400 Inclusion, Goldman Eyes 2026 Pipeline
Arrowhead Pharmaceuticals shares experienced heightened trading activity and a slight decline following its transition to the S&P MidCap 400 index. Goldman Sachs reiterated a Neutral stance, highlighting pivotal 2026 clinical data and competitive pressures.